Exact Mass: 468.2049
Exact Mass Matches: 468.2049
Found 439 metabolites which its exact mass value is equals to given mass value 468.2049
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(13E)-9-hydroxy-8alpha-labda-13-en-15-yl diphosphate
2-[1-[2-[(4-Carbamimidoylbenzoyl)amino]-3-(4-hydroxyphenyl)propanoyl]piperidin-4-yl]oxyacetic acid
1,2-Dihydro-8-hydroxyisopentanyl-2-methoxy-4-O-methylalpinumisoflavone
1,2-Dihydro-8-hydroxyisopentanyl-3-methoxy-4-O-methylalpinumisoflavone
2-Hydroxy-3,4-dimethoxy-isoflavane-7-O-??-D-glucoside
(4R)-alpha-terpineol 8-O-beta-D-(6-O-galloyl)glucopyranoside
(1S,4S,5R,7R,9S,10S)-9-benzoyloxy-1-(3-furoyloxy)-4-hydroxy-dihydro-beta-agarofuran
17-defurano-17-(2,5-dihydro-2-oxofuran-3-yl)-28-deoxonimbolide|methyl (2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cS)-8-(2,5-dihydro-2-oxo-3-furanyl)-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2a,5a,6a,7-tetramethyl-5-oxo-2H,5H-cyclopenta[d]naphtho[2,3-b:1,8-bc]difuran-6-acetate
5,3?-dihydroxy-7,4?-dimethoxy-6,8-dimethylallyl-2,3-dihydroflavonol|prenyl-isotirumalin
O-(6-Acetyl-beta-D-glucopyranoside)-(1beta,4alpha,5alpha,8beta)-4-Hydroxy-9,11(13)-guaiadien-12,8-olide
3-(2-hydroxypropyl)-9-(3-hydroxy-6,8-dimethyldeca-2,4,6-trienoyl)-(6aR)-6a-methyl-9,9a-dihydro-6aH-furo[2,3-h]isochromene-6,8-dione|sassafrin A
Ala Cys Ile Tyr
Ala Cys Leu Tyr
Ala Cys Tyr Ile
Ala Cys Tyr Leu
Ala Phe Met Thr
Ala Phe Thr Met
Ala His Asn Gln
Ala His Gln Asn
Ala Ile Cys Tyr
Ala Ile Tyr Cys
Ala Leu Cys Tyr
Ala Leu Tyr Cys
Ala Met Phe Thr
Ala Met Thr Phe
Ala Asn His Gln
Ala Asn Gln His
Ala Gln His Asn
Ala Gln Asn His
Ala Thr Phe Met
Ala Thr Met Phe
Ala Tyr Cys Ile
Ala Tyr Cys Leu
Ala Tyr Ile Cys
Ala Tyr Leu Cys
Cys Ala Ile Tyr
Cys Ala Leu Tyr
Cys Ala Tyr Ile
Cys Ala Tyr Leu
Cys Phe Ile Ser
Cys Phe Leu Ser
Cys Phe Ser Ile
Cys Phe Ser Leu
Cys Phe Thr Val
Cys Phe Val Thr
Cys Ile Ala Tyr
Cys Ile Phe Ser
Cys Ile Ser Phe
Cys Ile Tyr Ala
Cys Leu Ala Tyr
Cys Leu Phe Ser
Cys Leu Ser Phe
Cys Leu Tyr Ala
Cys Ser Phe Ile
Cys Ser Phe Leu
Cys Ser Ile Phe
Cys Ser Leu Phe
Cys Thr Phe Val
Cys Thr Val Phe
Cys Val Phe Thr
Cys Val Thr Phe
Cys Tyr Ala Ile
Cys Tyr Ala Leu
Cys Tyr Ile Ala
Cys Tyr Leu Ala
Asp His Pro Thr
Asp His Thr Pro
Asp Pro His Thr
Asp Pro Thr His
Asp Thr His Pro
Asp Thr Pro His
Glu His Pro Ser
Glu His Ser Pro
Glu Pro His Ser
Glu Pro Ser His
Glu Ser His Pro
Glu Ser Pro His
Phe Ala Met Thr
Phe Ala Thr Met
Phe Cys Ile Ser
Phe Cys Leu Ser
Phe Cys Ser Ile
Phe Cys Ser Leu
Phe Cys Thr Val
Phe Cys Val Thr
Phe Ile Cys Ser
Phe Ile Ser Cys
Phe Leu Cys Ser
Phe Leu Ser Cys
Phe Met Ala Thr
Phe Met Thr Ala
Phe Ser Cys Ile
Phe Ser Cys Leu
Phe Ser Ile Cys
Phe Ser Leu Cys
Phe Thr Ala Met
Phe Thr Cys Val
Phe Thr Met Ala
Phe Thr Val Cys
Phe Val Cys Thr
Phe Val Thr Cys
Gly His Gln Gln
Gly Met Val Tyr
Gly Met Tyr Val
Gly Gln His Gln
Gly Gln Gln His
Gly Val Met Tyr
Gly Val Tyr Met
Gly Tyr Met Val
Gly Tyr Val Met
His Ala Asn Gln
His Ala Gln Asn
His Asp Pro Thr
His Asp Thr Pro
His Glu Pro Ser
His Glu Ser Pro
His Gly Gln Gln
His Asn Ala Gln
His Asn Gln Ala
His Pro Asp Thr
His Pro Glu Ser
His Pro Ser Glu
His Pro Thr Asp
His Gln Ala Asn
His Gln Gly Gln
His Gln Asn Ala
His Gln Gln Gly
His Ser Glu Pro
His Ser Pro Glu
His Thr Asp Pro
His Thr Pro Asp
Ile Ala Cys Tyr
Ile Ala Tyr Cys
Ile Cys Ala Tyr
Ile Cys Phe Ser
Ile Cys Ser Phe
Ile Cys Tyr Ala
Ile Phe Cys Ser
Ile Phe Ser Cys
Ile Ser Cys Phe
Ile Ser Phe Cys
Ile Tyr Ala Cys
Ile Tyr Cys Ala
Leu Ala Cys Tyr
Leu Ala Tyr Cys
Leu Cys Ala Tyr
Leu Cys Phe Ser
Leu Cys Ser Phe
Leu Cys Tyr Ala
Leu Phe Cys Ser
Leu Phe Ser Cys
Leu Ser Cys Phe
Leu Ser Phe Cys
Leu Tyr Ala Cys
Leu Tyr Cys Ala
Met Ala Phe Thr
Met Ala Thr Phe
Met Phe Ala Thr
Met Phe Thr Ala
Met Gly Val Tyr
Met Gly Tyr Val
Met Thr Ala Phe
Met Thr Phe Ala
Met Val Gly Tyr
Met Val Tyr Gly
Met Tyr Gly Val
Met Tyr Val Gly
Asn Ala His Gln
Asn Ala Gln His
Asn His Ala Gln
Asn His Gln Ala
Asn Gln Ala His
Asn Gln His Ala
Pro Asp His Thr
Pro Asp Thr His
Pro Glu His Ser
Pro Glu Ser His
Pro His Asp Thr
Pro His Glu Ser
Pro His Ser Glu
Pro His Thr Asp
Pro Ser Glu His
Pro Ser His Glu
Pro Thr Asp His
Pro Thr His Asp
Gln Ala His Asn
Gln Ala Asn His
Gln Gly His Gln
Gln Gly Gln His
Gln His Ala Asn
Gln His Gly Gln
Gln His Asn Ala
Gln His Gln Gly
Gln Asn Ala His
Gln Asn His Ala
Gln Gln Gly His
Gln Gln His Gly
Ser Cys Phe Ile
Ser Cys Phe Leu
Ser Cys Ile Phe
Ser Cys Leu Phe
Ser Glu His Pro
Ser Glu Pro His
Ser Phe Cys Ile
Ser Phe Cys Leu
Ser Phe Ile Cys
Ser Phe Leu Cys
Ser His Glu Pro
Ser His Pro Glu
Ser Ile Cys Phe
Ser Ile Phe Cys
Ser Leu Cys Phe
Ser Leu Phe Cys
Ser Pro Glu His
Ser Pro His Glu
Thr Ala Phe Met
Thr Ala Met Phe
Thr Cys Phe Val
Thr Cys Val Phe
Thr Asp His Pro
Thr Asp Pro His
Thr Phe Ala Met
Thr Phe Cys Val
Thr Phe Met Ala
Thr Phe Val Cys
Thr His Asp Pro
Thr His Pro Asp
Thr Met Ala Phe
Thr Met Phe Ala
Thr Pro Asp His
Thr Pro His Asp
Thr Val Cys Phe
Thr Val Phe Cys
Val Cys Phe Thr
Val Cys Thr Phe
Val Phe Cys Thr
Val Phe Thr Cys
Val Gly Met Tyr
Val Gly Tyr Met
Val Met Gly Tyr
Val Met Tyr Gly
Val Thr Cys Phe
Val Thr Phe Cys
Val Tyr Gly Met
Val Tyr Met Gly
Tyr Ala Cys Ile
Tyr Ala Cys Leu
Tyr Ala Ile Cys
Tyr Ala Leu Cys
Tyr Cys Ala Ile
Tyr Cys Ala Leu
Tyr Cys Ile Ala
Tyr Cys Leu Ala
Tyr Gly Met Val
Tyr Gly Val Met
Tyr Ile Ala Cys
Tyr Ile Cys Ala
Tyr Leu Ala Cys
Tyr Leu Cys Ala
Tyr Met Gly Val
Tyr Met Val Gly
Tyr Val Gly Met
Tyr Val Met Gly
(R)-(+)-2,2-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6-dimethoxy-1,1-biphenyl,min.
Cotinine fumarate
C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist > C73579 - Nicotinic Agonist
lamifiban
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants
2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-hydroxy-5-phosphonopentanoic acid
[(E)-5-[(1S,2S,8aR)-2-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enyl] phosphono hydrogen phosphate
N-[(1S,3S,4aS,9aR)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aR,9aS)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aR,9aS)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
[(8R,9S,10R)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(2-methylphenyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
(2E)-5-[(1R,2R,4aS,8aS)-1-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl trihydrogen diphosphate
BAY-3827
BAY-3827 is a potent and selective AMPK inhibitor with IC50 values of 1.4 nM at low (10 μM ATP concentration) and 15 nM at high (2 mM ATP concentration). BAY-3827 shows over 500-fold selectivity for most of the 331 kinases. BAY-3827 prevents phosphorylation of acetyl-CoA carboxylase 1 and shows strongest anti-proliferative activity in androgen-dependent prostate cancer cell lines[1].
(2s)-2-(3,4-dihydroxy-5-methoxyphenyl)-6-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
(2s)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-[(3e,6e)-8-hydroxy-4,8-dimethylnona-3,6-dien-1-yl]-2,3-dihydro-1-benzopyran-4-one
6-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(1's,2r,2'r,4's,6'r,8's,9'r,10's,11'r,15'r,16's)-15'-(furan-3-yl)-10'-hydroxy-2',11',16'-trimethyl-3'-oxo-5'-oxaspiro[oxirane-2,7'-pentacyclo[9.7.0.0²,⁸.0⁴,⁶.0¹²,¹⁶]octadecan]-12'-en-9'-yl acetate
methyl 2-[(1r,2s,5r,6r,13s,16r)-6-(furan-3-yl)-1,5,15,15-tetramethyl-8,14,17-trioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]acetate
(2s)-6-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7-dihydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
methyl 2-{2-[6-(furan-3-yl)-7-methyl-11-methylidene-4-oxo-2,5-dioxatricyclo[5.4.0.0¹,³]undecan-10-yl]-2,6,6-trimethyl-5-oxocyclohex-3-en-1-yl}acetate
8-hydroxy-15-(4-methoxyphenyl)-2,7,7,11-tetramethyl-6,12,16-trioxatetracyclo[9.8.0.0²,⁸.0¹³,¹⁸]nonadeca-13(18),14-diene-5,17-dione
6-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
3-(2,4-dimethoxyphenyl)-5-hydroxy-10-(3-hydroxy-3-methylbutyl)-8,8-dimethyl-6h,7h-pyrano[3,2-g]chromen-4-one
(1s,2r,3r,4s,5r,6s)-2-(acetyloxy)-3,5-dihydroxy-4,6-bis({[(2z)-2-methylbut-2-enoyl]oxy})cyclohexyl (2z)-2-methylbut-2-enoate
5-[(1,3-dihydroxybutylidene)amino]-2-(2,3-dihydroxypropoxy)-3,4-dihydroxy-6-{2-hydroxy-1-[(1-hydroxyethylidene)amino]propyl}oxane-2-carboxylic acid
(2r)-1-[(1r,4as,7s,7ar)-1-(4-hydroxy-5-methyl-2-oxochromen-3-yl)-4,7-dimethyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-3-yl]-3-methyl-1-oxobutan-2-yl acetate
(2s,3s,4r,4as,5s,8r,8ar)-5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-octahydro-1h-naphthalen-2-yl (3s)-4-(acetyloxy)-3-hydroxy-2-methylidenebutanoate
2'-hydroxy-3',4'-dime thoxy-isoflavane-7-o-β-d-glucoside
{"Ingredient_id": "HBIN005735","Ingredient_name": "2'-hydroxy-3',4'-dime thoxy-isoflavane-7-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C23H32O10","Ingredient_Smile": "COC1C=CC(C(C1OC)O)C2CC3=C(C=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O)OC2","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15836","TCMID_id": "10030","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}